Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Item
http://www.wikidata.org/entity/Q38199178
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practiceDevelopment of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survival.Does the use of lapatinib increase the risk of fatigue and hepatic toxicities in patients with solid tumors? A critical literature review and meta-analysis.Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib: a critical review and meta analysis.Risk of fatigue and hepatic and metabolic toxicities in patients with solid tumors treated with everolimus: a meta-analysis.Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside.Hand-foot skin reaction is a beneficial indicator of sorafenib therapy for patients with hepatocellular carcinoma: a systemic review and meta-analysis.
P2860

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Item
http://www.wikidata.org/entity/Q38199178
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk of mucocutaneous toxiciti ...... atic review and meta-analysis.
@en
type
label
Risk of mucocutaneous toxiciti ...... atic review and meta-analysis.
@en
prefLabel
Risk of mucocutaneous toxiciti ...... atic review and meta-analysis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Risk of mucocutaneous toxiciti ...... matic review and meta-analysis
@en
P2093
P2860
P304
P31
P356
10.1586/14737140.2014.894465
P433
P478
P50
P577
P698